NUTRA PHARMA CORP.


          CERTIFICATION OF CHIEF FINANCIAL OFFICER
                  PURSUANT TO SECTION 302
             OF THE SARBANES-OXLEY ACT OF 2002

                                               Exhibit 31.2

  I, Zirk Engelbrecht, Vice President and Chief Financial Officer of Nutra
  Pharma Corp. (the "Company") certify that:

  1. I have reviewed this quarterly report on Form 10-QSB of the Company;

  2. Based on my knowledge, this quarterly report does not contain any
  untrue statement of a material fact or omit to state a material fact
  necessary to make the statements made, in light of the circumstances
  under which such statements were made, not misleading with respect to
  the period covered by this quarterly report;

  3. Based on my knowledge, the financial statements, and other financial
  information included in this quarterly report, fairly present in all
  material respects the financial condition, results of operations and
  cash flows of the Company as of, and for, the periods presented in this
  quarterly report;

  4. The Company's other certifying officer and I, are responsible for
  establishing and maintaining disclosure controls and procedures (as
  defined in Exchange Act Rules 13a-14 and 15d-14) for the Company and
  have:

  a) designed such disclosure controls and procedures, or caused such
  disclosure controls and procedures to be designed, under our supervision
  to ensure that material information relating to the Company, including
  any subsidiaries, is made known to us by others within those entities,
  particularly during the period in which this quarterly report is being
  prepared;

  b) evaluated the effectiveness of the Company's disclosure controls and
  procedures, and presented in this report, our conclusions about the
  effectiveness of the disclosure controls and procedures, as of the end
  of the period covered by this report based on such evaluation; and

  c) disclosed in this report any change in the Company's internal control
  over financial reporting that occurred during the Company's most recent
  fiscal quarter (the Company's fourth fiscal quarter in the case of an
  annual report) that has materially affected, or is reasonably likely to
  materially affect, the Company's internal control over financial
  reporting;

  5. The Company's other certifying officer and I have disclosed, based on
  our most recent evaluation of internal control over financial reporting,
  to the Company's auditors and the audit committee of the Company's board
  of directors (or persons performing the equivalent function);

  a) all significant deficiencies and material weaknesses in the design or
  operation of internal controls over financial reporting which are
  reasonably likely to adversely affect the Company's ability to record,
  process, summarize and report financial information and any fraud,
  whether or not material, that involves management or other employees who
  have a significant role in the Company's internal controls over
  financial reporting.



  /s/ Zirk Engelbrecht
  ------------------------
  By:  Zirk Engelbrecht
  Its: Vice President and Chief Financial Officer

  Date: November 19, 2003